Table 5. Results of multiple regression analysis.
Received support as moderator of relation between PTG and positive affect and negative affect.
| Dependent | Block | Predictor | Assessment | β | ΔR2 |
|---|---|---|---|---|---|
| Positive affect | First | Stable Relationship | Third | -.22 (-.44÷-.01) | .05 |
| Second | CD4 | Third | .01 (-.26÷.21) | - | |
| HIV Duration | Third | -.03 (-.36÷.55) | |||
| ARV Duration | Third | -.07 (-.54÷.34) | |||
| HIV/AIDS Status | Third | -.09 (-.36÷.13) | |||
| Third | Stable Relationship | Third | -.21 (-.40÷-.02) | .22 | |
| +Positive Affect | First | .47 (.28÷.66) | |||
| Fourth | Stable Relationship | Third | -.15 (-.35÷.04) | .04 | |
| Positive Affect | First | .42 (.20÷.61) | |||
| +PTG | First | .15 (-.06÷.34) | |||
| + Actually Received Support | Second | .15 (-.07÷.34) | |||
| Fifth | Stable Relationship | Third | -.12 (-.36÷.03) | .04 | |
| Positive Affect | First | .40 (.18÷.57) | |||
| PTG | First | .17 (-.03÷.37) | |||
| Actually Received Support | Second | .19 (-.07÷.33) | |||
| +PTG x Actually Received Support | First/Second | .20 (.01÷.38) | |||
| Negative affect | First | Gender | First | .27 (.06÷.49) | .07 |
| Second | CD4 | Third | .09 (-.17÷.30) | - | |
| HIV Duration | Third | .04 (-.26÷.64) | |||
| ARV Duration | Third | -.03 (-.54÷.34) | |||
| HIV/AIDS Status | Third | .07 (-.11÷.38) | |||
| Third | Gender | First | .25 (.04÷.47) | .02 | |
| Negative Affect | First | .14 (-.07÷.36) | |||
| Fourth | Gender | First | .24 (.01÷.47) | .01 | |
| Negative Affect | First | .15 (-.09÷.36) | |||
| PTG | First | .03 (-.19÷.27) | |||
| Actually Received Support | Second | .05 (-.29÷.15) | |||
| Fifth | Gender | First | .23 (-.01÷.48) | .01 | |
| Negative Affect | First | .15 (-.09÷.36) | |||
| PTG | First | .03 (-.19÷.28) | |||
| Actually Received Support | Second | .04 (-.29÷.15) | |||
| PTG x Actually Received Support | First/Second | -.07 (-.20÷.23) |
Note:β–Standardized Regression Coefficients with 95% Confidence Intervals; ΔR2 –Change of the Variance Explained.